Funder: Michael J. Fox Foundation for Parkinson's Research
Due Dates: January 11, 2024 | March 14, 2024 | May 16, 2024 | July 18, 2024
Funding Amounts: $250,000–$2,000,000 per project; 1–2 years (pre-clinical), 2–3 years (clinical)
Summary: Supports industry and academia-industry partnerships to advance novel Parkinson’s disease therapies through pre-clinical and clinical development.
Key Information: Pre-proposals accepted any time; only industry or academia-industry collaborations are eligible.